Regulatory T cell reprogramming heads to trial in 2026
Most people have heard of cancer immunotherapy by now. These treatments help a patient's own immune system recognize and attack cancer. The best-known examples are immune checkpoint inhibitors such as pembrolizumab (Keytruda) and nivolumab (Opdivo). These drugs release certain "brakes"…
Most people have heard of cancer immunotherapy by now. These treatments help a patient’s own immune system recognize and attack cancer. The best-known examples are immune checkpoint inhibitors such as pembrolizumab (Keytruda) and nivolumab (Opdivo). These drugs release certain “brakes” that normally keep the immune system from becoming overactive. Another approach, called CAR-T therapy, is more involved. Doctors remove some of a patient’s T cells, a type of white blood …
Regulatory T cell reprogramming heads to trial in 2026




















